Novartis to Report Q4 Earnings: What's in the Offing?

Published on 28 Jan 2025 on Zacks · via Yahoo Finance

Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year...

Read the rest of the article

Start tracking your investments with Statfolio

Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis. W...

Zacks · via Yahoo Finance 25 Feb 2025

A cost-saving effort by NHS England to transition multiple sclerosis (MS) patients from Biogen In...

Benzinga · via Yahoo Finance 24 Feb 2025

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. I...

Insider Monkey · via Yahoo Finance 23 Feb 2025

Last year, the Vanguard S&P 500 Growth ETF ranked as the biggest winner among Vanguard's...

Motley Fool · via Yahoo Finance 23 Feb 2025

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this...

Insider Monkey · via Yahoo Finance 20 Feb 2025

Samarth Kulkarni, the Chief Executive Officer of CRISPR Therapeutics AG (NASDAQ:CRSP), recently s...

Investing.com 20 Feb 2025

There are many opportunities available in the international markets that never make the news in t...

247wallst.com 18 Feb 2025

We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. ...

Insider Monkey · via Yahoo Finance 14 Feb 2025

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In t...

Insider Monkey · via Yahoo Finance 6 Feb 2025

CRSP beat on earnings in three of the trailing four quarters and missed the mark in the other,...

Zacks · via Yahoo Finance 3 Feb 2025